Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous vs Sequential Pneumococcal and Influenza Vaccination
NCT02592486Phase 4Completed
- Sponsor
- Kameda Medical Center
- Start
- Nov 2015
- Primary completion
- Mar 2016
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 23-valent pneumococcal polysaccharide vaccine, Afluria in Pneumococcal pneumonia (PP), influenza, sponsored by Kameda Medical Center. Started Nov 2015; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccineAfluria
03
Conditions
Pneumococcal pneumonia (PP)influenza
Beyond the preview
Go deeper on NCT02592486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02592486.